Short Regimen for Preventing TB Found Safe When Co-administered with New First-line HIV Drug.
Welcome to The Aurum Institute - A Leading African Health Impact Organisation
Congratulations to the Aurum Ghana team! The "TB REACH Wave 6" application, 1109: Engaging private health providers & National Health Insurance to scale up active TB case finding among vulnerable populations, was part of 42 applications, selected out of over 570, for funding.
Unitaid is investing US$59 million in Aurum's IMPAACT4TB (Increasing Market and Public health outcomes through scaling up Aﬀordable Access models of short Course preventive therapy for TB) project, to prevent people most vulnerable to developing active TB, including people living with HIV and children under age five, from developing active TB disease.